GNH USA

Europe — EMA

Nimm (Nimesulide)

GNH USA supplies Nimm (Nimesulide), an NSAID for pain relief, fever reduction and inflammation control. Request a quote for international global supply.

Nimesulide

Request sourcing

1
Pack/s

What is Nimesulide?

Nimesulide, the active ingredient in Nimm, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is employed to relieve pain, reduce fever, and manage inflammation in adult patients. The medication is indicated for conditions such as osteoarthritis, dysmenorrhea, and acute musculoskeletal pain.

GNH USA supplies Nimm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, with consistent quality standards and research institutions.

What is Nimesulide used for?

Nimesulide acts on inflammatory pathways to provide analgesic, antipyretic and anti‑inflammatory effects. - Acute pain: Reduces discomfort associated with short‑term musculoskeletal injuries. - Fever: Lowers elevated body temperature in febrile conditions. - Osteoarthritis: Improves joint pain and functional mobility in chronic degenerative disease. - Dysmenorrhea: Alleviates menstrual cramps and associated pelvic pain. - Inflammatory conditions: Controls swelling and tenderness in acute inflammatory states.

What are the side effects of Nimesulide?

Nimesulide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash: mild erythema or itching. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury or failure. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Severe hypersensitivity reactions: anaphylaxis or angioedema. - Gastrointestinal bleeding or ulceration. - Renal impairment: acute kidney injury.

What precautions apply to Nimesulide?

Before prescribing Nimesulide, clinicians should evaluate patient history and monitor specific parameters. - Assess liver function: perform baseline hepatic enzyme tests and monitor periodically. - Evaluate renal status: check kidney function in patients with pre‑existing renal disease. - Review cardiovascular risk: avoid use in patients with uncontrolled hypertension or heart failure. - Check for gastrointestinal history: use cautiously in those with ulcer disease or bleeding tendencies. - Avoid in patients with known hypersensitivity to NSAIDs: discontinue at first sign of allergic reaction. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Nimesulide interact with?

Nimesulide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - Lithium: Nimesulide may raise lithium serum levels. - Methotrexate: potential for enhanced toxicity. - Cyclosporine: increased risk of nephrotoxicity. - SSRIs (e.g., sertraline): may augment bleeding tendency. - Diuretics: possible reduction in antihypertensive effect.

Frequently asked questions

What is Nimm used for?+
Nimm contains Nimesulide, an NSAID indicated for relief of mild to moderate pain, reduction of fever, and control of inflammation associated with conditions such as osteoarthritis, dysmenorrhea and acute musculoskeletal injuries. It is prescribed for adult patients when a selective COX‑2 inhibitor is appropriate.
How does Nimesulide work?+
Nimesulide works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which blocks the conversion of arachidonic acid to prostaglandins. This reduction in prostaglandin production diminishes the inflammatory response, lowers pain signaling, and helps normalize elevated body temperature.
What is the usual dose of Nimm?+
The dosage of Nimm is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and renal or hepatic function. Only a qualified prescriber should set the dose and duration of therapy; patients should follow the written prescription exactly.
Is Nimm safe during pregnancy or breastfeeding?+
The safety of Nimesulide in pregnancy and lactation has not been established, and it is generally avoided, especially in the third trimester, due to potential fetal risks. Breastfeeding mothers should consult their physician, as the drug may be excreted in milk.
How do I order Nimm from GNH USA?+
To order Nimm, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Nimm compare with other NSAIDs?+
Compared with non‑selective NSAIDs, Nimesulide offers selective COX‑2 inhibition, which may reduce the incidence of gastrointestinal irritation while still providing effective analgesic and antipyretic action. However, it shares similar risks of hepatic effects and should be chosen based on individual patient risk profiles.
How should Nimm be stored?+
Nimm tablets should be stored at ambient temperature below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Do not store in a refrigerator or freezer, and keep out of reach of children.
How is Nimm administered?+
Nimm is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with meals can lessen mild gastrointestinal discomfort. Patients should swallow the tablet whole and not split or crush it unless instructed by a healthcare professional.
What are the most serious risks associated with Nimm?+
The most serious adverse reactions to Nimesulide include severe liver injury, such as hepatitis or hepatic failure, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Prompt medical attention is required if signs of jaundice, dark urine, rash, or blistering develop.
Who should not use Nimm?+
Nimm should be avoided in patients with known hypersensitivity to Nimesulide or other NSAIDs, those with active peptic ulcer disease, severe hepatic or renal impairment, uncontrolled hypertension, and in the third trimester of pregnancy. Consultation with a physician is essential before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nimesulide
Route
Oral Use
Manufacturer
Codal Synto Ltd
Origin
EU

Related products

Actalide

Actalide

Nimesulide

Errekappa Euroterapici Spa
EU
Actalide

Actalide

Nimesulide

Errekappa Euroterapici Spa
EU
Algolider

Algolider

Nimesulide

Siar Pharma S.R.L.
EU
Aponil

Aponil

Nimesulide

Medochemie Ltd.
EU